Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps ...

28 September 2026 · By · Wire by Fusion42

Published

28 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

Africa

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 28 September 2026 · Fusion42 review

Eli Lilly launches the Lilly Change the Course Commitment to provide parity in diabetes and obesity treatment access between low- and middle-income countries (LMICs) and high-income countries by 2040, focusing on medicine development, regulatory registration, and health system strengthening.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You should prepare for increased demand in diabetes and obesity care in LMICs driven by Lilly's commitment to regulatory engagement and health system support. This opens new market opportunities for solutions that aid medicine distribution and healthcare training in these regions.

◆ Coverage

1 source · 28 Sep 2026

◆ Related on Wire

◆ Topics

Healthdiabetes-treatmentobesity-medicineslow-and-middle-income-countrieshealth-equityglobal-health